Rates of Refusal to Participate in Research Studies Among Men and Women

Psychiatric Services

Volumn 54, Issue 11, 2003, Pages 1541-1544

  Covell, Nancy H ^a,b   Frisman, Linda K ^a,b   Essock, Susan M ^c,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Research Division   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Mental Illness Res/Educ/Clin Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL RESEARCH; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; METHODOLOGY; RISK ASSESSMENT; SAMPLING; SCHIZOPHRENIA; SEX DIFFERENCE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ADULT; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0242362744     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.11.1541     Document Type: Article

References (7)

1. Robinson D, Woerner MG, Pollack S, et al: Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study. Journal of Clinical Psychopharmacology 16:170-176, 1996
2. Mohr P, Czorbor P: Subject selection for the placebo- and comparator-controlled trials of neuroleptics in shizophrenia. Journal of Clinical Psychopharmacology 20:240-245, 2000
3. Spohn HE, Fitzpatrick T. Informed consent and bias in samples of schizophrenic subjects at risk for drug withdrawal. Journal of Abnormal Psychology 89:79-92, 1980
4. Hofer A, Hummer M, Huber R, et al: Selection bias in clinical trials with antipsychotics. Journal of Clinical Psychopharmacology 20:699-702, 2000
5. Essock SM, Hargreaves WA, Dohm FA, et al: Clozapine eligibility among state hospital patients. Schizophrenia Bulletin 22:15-25, 1996
6. Mueser KT, Essock SM, Drake RE, et al: Rural and urban differences in patients with a dual diagnosis. Schizophrenia Research 48:93-107, 2001
7. Rosenberg SD, Goodman LA, Osher FC, et al: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health 91:31-37, 2001